New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 10, 2015, Pages 756-758

  McAninch, Elizabeth A ^a   Bianco, Antonio C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LEVOTHYROXINE; LIOTHYRONINE; THREONINE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II;

CONTROLLED CLINICAL TRIAL (TOPIC); DOWN REGULATION; DRUG EFFICACY; EUTHYROIDISM; GENETIC POLYMORPHISM; GOLGI COMPLEX; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROID FUNCTION; THYROIDECTOMY; WEIGHT REDUCTION; ANIMAL; GENETICS; PROCEDURES;

ANIMALS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; THYROXINE; TRIIODOTHYRONINE;

EID: 84941803528     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00325-3     Document Type: Note

References (12)

1. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 2014, 24:1670-1751.
2. Werner SC Treatment; myxedema coma; nonspecific uses of thyroid medication. The thyroid: a fundamental and clinical text 1971, 832-838. Harper & Row, New York, NY. 3rd edn. S.C. Werner, S.H. Ingbar (Eds.).
3. Utiger RD Thyrotrophin radioimmunoassay: another test of thyroid function. Ann Intern Med 1971, 74:627-629.
4. Braverman LE, Ingbar SH, Sterling K Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic subjects. J Clin Invest 1970, 49:855-864.
5. Gorman CA, Jiang NS, Ellefson RD, Elveback LR Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients. J Clin Endocrinol Metab 1979, 49:1-7.
6. Duntas LH Thyroid disease and lipids. Thyroid 2002, 12:287-293.
7. Werneck de Castro JP, Fonseca TL, Ueta CB, et al. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest 2015, 125:769-781.
8. Escobar-Morreale HF, Rey F, Obregon MJ, Escobar GM Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 1996, 137:2490-2502.
9. Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 2009, 94:1623-1629.
10. Canani LH, Capp C, Dora JM, et al. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2005, 90:3472-3478.
11. Peeters RP, van Toor H, Klootwijk W, et al. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 2003, 88:2880-2888.
12. McAninch EA, Jo S, Preite NZ, et al. Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J Clin Endocrinol Metab 2015, 100:920-933.